Zhitong Finance App News, Xuantai Pharmaceutical (688247.SH) issued an announcement. Recently, the company participated in the bid for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office. According to the “Announcement of the Proposed Selection Results for the 12th Batch of Centralized Volume Procurement of National Organization Drugs” issued by the Joint Procurement Office on July 31, 2026, on the Shanghai Sunshine Pharmaceutical Procurement Network, the company's products are expected to be selected for this centralized procurement.

This centralized procurement is the 12th batch of centralized procurement of national drugs organized by the Joint Procurement Office. During the procurement cycle, medical institutions will give priority to using the winning drugs and ensure that the agreed procurement volume is completed. If the company subsequently signs a procurement contract and implements it, it will help to further expand the sales scale of products, increase market share, promote the development of the domestic market for the company's related products, enhance the company's brand influence, and have a positive impact on the company's future business performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.